Mealey's (May 16, 2023, 9:19 AM EDT) -- WASHINGTON, D.C. — A decision on rehearing by the Federal Circuit U.S. Court of Appeals that reinstated a $234 million award in favor of GlaxoSmithKline LLC (GSK) will stand in light of the U.S. Supreme Court’s May 15 denial of a generic drugmaker’s petition for writ of certiorari....